Physician profile
Won Jun Park
NPI 1144645979
$1,215.27
in general payments reported to CMS, 2019-2025
13 companies · $39.10 in 2025
The $39.10 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $230 · 2020: $15.47 · 2021: $247 · 2022: $113 · 2023: $123 · 2024: $448 · 2025: $39.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $610.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $609.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $541.51 | 2021-2025 | Mitraclip, Triclip, Thoratec Heartmate 3 Lvas Implant Kit |
| Kestra Medical Technology Services, INC. | $143.99 | 2022-2024 | Assure Wcd |
| Astrazeneca Pharmaceuticals Lp | $133.48 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $93.01 | 2019-2024 | Jardiance |
| Boston Scientific Corporation | $56.42 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $54.19 | 2021-2022 | |
| Baxter Healthcare | $47.57 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Pfizer INC. | $35.13 | 2022-2023 | |
| Chiesi USA, INC. | $29.79 | 2019 | |
| Cardiva Medical, INC. | $24.38 | 2019 | |
| Astellas Pharma US INC | $21.26 | 2019 | |
| Novartis Pharmaceuticals Corporation | $18.95 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $15.59 | 2024 | Camzyos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Won Jun Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.